Indeed, even though the dysregulation of the amyloid processing and tau-related hyperphosphorylation and neurodegeneration are at the core of the biological definition of AD, several other molecular changes have been reported across the Alzheimer’s continuum [6]. This evidence concerns the gene MAPT and Alzheimer disease.